Document is current
Any future updates will be listed below
-
Authors
Dayem, Hussein Abdel
Al Hammadi, Anwar
Reda, Ashraf
Albreiki, Fatima
Al Naeem, Ayman
Ameen, Ahmed
Ahmed, Mohamed
Ali, Huda Rajab
Elrayes, Mohamed
Senay, Gozde
Al Murrawi, Muna
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
Received: 6 June 2025
Accepted: 11 September 2025
First Online: 29 September 2025
Declarations
:
: Hussein Abdel Dayem has received honoraria from AbbVie, Eli Lilly and Company, Johnson & Johnson, Leo, Novartis, and Pfizer. Ayman Al Naeem is a board member at Emirates Dermatology Society. Ahmed Ameen has received payment or honoraria for lectures, presentations, speakers bureaus, abstract (and subsequent poster) writing, or educational events from AbbVie, Eli Lilly and Company, Janssen, Leo, Pfizer, and Sanofi. Mohamed Elrayes and Gozde Senay are employees of and minor stakeholders in Eli Lilly and Company. Anwar Al Hammadi, Ashraf Reda, Fatima Albreiki, Huda Rajab Ali, Mohamed Ahmed and Muna Al Murrawi have nothing to disclose.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
